1. THU0136 Cardiovascular safety findings in rheumatoid arthritis patients treated with tofacitinib (CP-690, 550), a novel, oral jak inhibitor. (23rd January 2014) Authors: Charles-Schoeman, C.; Wicker, P.; Sechtem, U.; Gonzalez-Gay, M.A.; Wood, S.; Boy, M.; Geier, J.; Gruben, D.; Soma, K.; Riese, R.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗